Cognitive function and blood pressure control in hypertensive patients over 60 years of age: COGNIPRES study

Current Medical Research and Opinion

Volumn 24, Issue 12, 2008, Pages 3331-3340

  Vinyoles, Ernest ^a,c   De La Figuera, Mariano ^a   Gonzalez Segura, Diego ^b  

^a Instituto de Salud Carlos III   (Spain)

^b Laboratorios ALMIRALL SA ^*  (Spain)

^c Centre de Salut La Mina   (Spain)

Author keywords

Ambulatory blood pressure control; Cognitive function; Compliance

Indexed keywords

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ANXIETY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; ESSENTIAL TREMOR; FEMALE; HEALTH CARE FACILITY; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PATIENT COMPLIANCE; PREVALENCE; PRIMARY MEDICAL CARE; SPAIN; STROKE; TRANSIENT ISCHEMIC ATTACK; BLOOD PRESSURE; CLINICAL TRIAL; HYPERTENSION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SPAIN;

EID: 62349134982     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802538724     Document Type: Article

References (64)

1. Rigaud AS, Forette B. Hypertension in older adults. J Gerontol A Biol Sci Med Sci 2001;56:M217-225 (Pubitemid 32290888)
2. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanism in ischemic stroke pathogenesis and implications for therapy. Stroke 2002;33:862-875 (Pubitemid 34204018)
3. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (VI JNC). Arch Intern Med 1997;157:2413-2446 (Pubitemid 27517978)
4. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7-Complete Version. Hypertension 2003;42:1206-1252 (Pubitemid 37553153)
5. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO/International Society of hypertension (ISH) statement of hypertension. J Hyperten 2003;21:1983-1992
6. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-1129 (Pubitemid 36547501)
7. De Groot JC, de Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-341 (Pubitemid 35001500)
8. Vermeer SE, Prins N, Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222 (Pubitemid 36359297)
9. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041 (Pubitemid 41253271)
10. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-1534 (Pubitemid 39350263)
11. Rigaud AS, Hanon O, Seux ML, et al. Hypertension and dementia. Curr Hypertens Rep 2001;3:454-457
12. Forette F, Amery A, Staessen J, et al. Is prevention of vascular dementia possible? The Syst-Eur Vascular Dementia Project. Aging 1991;3:373-382
13. SHEP Cooperative Research GroupPrevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the elderly program (SHEP). JAMA 1991;265:3255-3264
14. PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041
15. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-1351 (Pubitemid 28510916)
16. Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998;31:780-786 (Pubitemid 28108576)
17. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-1075 (Pubitemid 36548935)
18. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature. Curr Med Res 2007;23:13-18
19. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74 (Pubitemid 16125389)
20. Torre J, Fernández R, López J, et al. [Treatment adherence and BP control study in urban population.]. Rev Clin Esp 1990;187:103-106
21. Val A, Amorós G, Martínez P, et al. [Adherence to pharmacologic antihypertensive treatment and validation of Morisky-Green test descriptive study.]. Aten Prim 1992;10:767-770
22. Gil VF, Pineda M, Martínez JL, et al. [Validity of 6 indirect methods to assess therapeutic adherence in HBP.]. Med Clin 1994;102:532-536
23. Practical aspects of drug treatment in elderly patients with mobility problems. Drugs Aging 1999;14:105-114 (Pubitemid 29086112)
24. McCormack PME, Lawlor R, Donegan C, et al. Knowledge and attitudes to prescribed drugs in young and elderly patients. Irish Med J 2000;90:29-30
25. Kyngas H, Lahdenpera T. Compliance of patients with hypertension and associated factors. J Adv Nurs 1999;29:832-839
26. Folstein MF, Folstein S, McHugh RP. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
27. García García FJ, Sánchez Ayala MI, Pérez Martín A, et al. [The prevalence of dementia and its main subtypes in subjects older than 65 years: the effects of occupation and education. Toledo Study.]. Med Clin (Barc) 2001;116:401-407
28. Escribano-Aparicio MV, Pérez-Dively M, García García FJ, et al. Validation of Folstein's MMSE in a Spanish low educated population. Rev Esp Geriatr Gerontol 1999;34:319-326
29. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-764
30. Ferran M, Parcet J, Casabella B, et al. [Health education to hypertensive patients: proposal of an information and adherence test.]. Aten Prim 1988;5:25-30
31. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-1451 (Pubitemid 32575406)
32. Gustafson D, Rothenberg E, Blennow K, et al. An 18-year follow-up of overweight and risk of Alzheimer's disease. Arch Intern Med 2003;163:1524-1528 (Pubitemid 36835095)
33. Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997;42:776 (Pubitemid 27481550)
34. Quiu C, von Strauss E, Fastbom J, et al. Low blood pressure and risk of dementia in the Kungsholmen Project. A 6-year follow-up study. Arch Neurol 2003;60:223-228
35. Verghese J, Lipton RB, Hall CB, et al. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003;61:1667-1672 (Pubitemid 38020809)
36. Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke 2003;34:2617-2622 (Pubitemid 37392753)
37. Srikanth VK, Thrift AG, Saling MM, et al. Increased risk of cognitive impairment 3 months after mild to moderate first-ever stroke: a community-based prospective study of nonaphasic English-speaking survivors. Stroke 2003;34:1136-1143 (Pubitemid 36547503)
38. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222 (Pubitemid 36359297)
39. Kuller LH. [Risk factors for dementia in the Cardiovascular Health Study cognition study.]. Rev Neurol 2003;37:122-126
40. Sakakura K, Hoshide S, Ishikawa J, et al. Association of body mass index with cognitive function in elderly hypertensive Japanese. Am J Hypertens 2008;21:627-632 (Pubitemid 351733366)
41. Wolf PA, Beiser A, Elias MF, et al. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res 2007;4:111-116 (Pubitemid 46557497)
42. González Juanatey JR, Alegría Ezquerra E, Lozano Vidal JV, et al. [The role of high blood pressure in cardiac diseases in Spain. The CARDIOTENS Study 1999.]. Rev Esp Cardiol 2001;54:139-149
43. Coca A. [Improvement on BP control in Spain: results from the CONTROLPRES 98 Study.]. Hipertensión 1998;15:298-306
44. Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the health examinations surveys, 1960 to 1991. Hypertension 1995;26:60-69
45. Joffres MR, Gharidian P, Fodor JG, et al. Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997;10:1097-1102 (Pubitemid 27486342)
46. Colhoun HM, Dong W, Poulter NR.xBlood pressure screening, management and control in England: results from the Health Survey for England 1994. J Hypertens 1998;16:747-752
47. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: is the "rule of halves" still valid? J Hum Hypertens 1997;111:213-220
48. Llisterri Caro JL, Rodriguez Coca GC, Alonso Moreno FJ, et al. [Blood pressure control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study.]. Med Clin (Barc) 2004;122:165-171
49. Coca A. [Blood pressure control among treated hypertensive patients by Primary Care in Spain. The 2003 Controlpres study.]. Hipertensión 2005;22:5-14
50. Gil VF, Merino J. [Adherence: deciding factor in hypertensive patient treatment.]. Iberoam J Hypertens 1996;1(Suppl 2):13-17
51. Piñeiro F, Gil VF, Donis M, et al. [Relation between medical treatment compliance and degree of control in patients with high blood pressure, non insulin dependent diabetes mellitus and hyperlipidemia.]. Med Clin (Barc) 1998;11:565-567
52. Márquez Contreras E, Gil Guillén V. Estrategias para mejorar el cumplimiento terapéutico. In: De la Figuera M, Diogène E, Brotons C, eds. Hipertensión arterial en Atención Primaria. Evidencia y práctica clínica. 2nd edn, Barcelona, Euromedice 2007;265-313
53. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497 (Pubitemid 41127293)
54. Banegas JR, Rodríguez-Artalejo F, Ruilope LM, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertension 2002;20:2157-2164 (Pubitemid 35388233)
55. Obisesan TO, Obisesan OA, Martins S, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 2008;56:501-509 (Pubitemid 351327944)
56. Forette F, Panisset M, Boller F. Clinical trials in cognitive impairment in the elderly. Aging 1992;4:239-250
57. Basile JN, Chrysant S. The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. J Hum Hypertens 2006;20:169-175
58. Hanon O, Forette F. Prevention of dementia: lessons from SYST-EUR and PROGRESS. J Neur Sci 2004;226:71-74 (Pubitemid 39505410)
59. Vilalta-Franch J, López Pousa S, Llinàs-Reglà J. [The prevalence of dementias in a rural area. A study in Girona.]. Rev Neurol 2000;30:1026-1032
60. Ritchie K, Kildea D. Is senile dementia "age related" or "ageing related"?: evidences from meta-analysis of dementia prevalence in the oldest old. Lancet 1995;346:931-934
61. Zunzunegui MV, del Ser T, Rodríguez A, et al. [Non-detected dementia and use of the health services: implications for primary care.]. Aten Primaria 2003;31(9):581-586
62. Del Ser T, Morales JM, Barquero MS, et al. Application of a Spanish version of the "Informant Questionnaire on cognitive decline in the elderly" in the clinical assessment of dementia. Alzheimer Dis Assoc Disord 1997;11:3-8
63. Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-1117 (Pubitemid 351731741)
64. 2007 Guidelines for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2007;9(Suppl C):C3-74